Evolving approach and clinical significance of detecting DNA mismatch repair deficiency in colorectal carcinoma

被引:46
|
作者
Shia, Jinru [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA
关键词
Lynch syndrome; Lynch-like syndrome; CMMR-D; Sporadic MSI cancer; Microsatellite instability; MMR IHC; LYNCH-SYNDROME; MICROSATELLITE-INSTABILITY; COLON-CANCER; FREQUENT CAUSE; GERMLINE MUTATIONS; RISK; DELETIONS; GENE; MLH1; MSH2;
D O I
10.1053/j.semdp.2015.02.018
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The last two decades have seen significant advancement in our understanding of colorectal tumors with DNA mismatch repair (MMR) deficiency. The ever-emerging revelations of new molecular and genetic alterations in various clinical conditions have necessitated constant refinement of disease terminology and classification. Thus, a case with the clinical condition of hereditary non-polyposis colorectal cancer as defined by the Amsterdam criteria may be one of Lynch syndrome characterized by a germline defect in one of the several MMR genes, one of the yet-to-be-defined "Lynch-like syndrome" if there is evidence of MMR deficiency in the tumor but no detectable germline MMR defect or tumor MLH1 promoter methylation, or "familial colorectal cancer type X" if there is no evidence of MMR deficiency. The detection of these conditions carries significant clinical implications. The detection tools and strategies are constantly evolving. The Bethesda guidelines symbolize a selective approach that uses clinical information and tumor histology as the basis to select high-risk individuals. Such a selective approach has subsequently been found to have limited sensitivity, and is thus gradually giving way to the alternative universal approach that tests all newly diagnosed colorectal cancers. Notably, the universal approach also has its own limitations; its cost-effectiveness in real practice, in particular, remains to be determined. Meanwhile, technological advances such as the next-generation sequencing are offering the promise of direct genetic testing for MMR deficiency at an affordable cost probably in the near future. This article reviews the up-to-date molecular definitions of the various conditions related to MMR deficiency, and discusses the tools and strategies that have been used in detecting these conditions. Special emphasis will be placed on the evolving nature and the clinical importance of the disease definitions and the detection strategies. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:352 / 361
页数:10
相关论文
共 50 条
  • [31] Mismatch repair deficiency in rectal cancer: an evolving scenario
    Longo, Federico
    Carrato, Alfredo
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (18)
  • [32] DNA mismatch repair and colorectal cancer
    Toft, NJ
    Arends, MJ
    JOURNAL OF PATHOLOGY, 1998, 185 (02): : 123 - 129
  • [33] Uterine endometrial carcinoma with DNA mismatch repair deficiency: magnetic resonance imaging findings and clinical features
    Minamiguchi, Kiyoyuki
    Takahama, Junko
    Uchiyama, Tomoko
    Taiji, Ryosuke
    Saito, Natsuhiko
    Okada, Hiroshi
    Marugami, Nagaaki
    Tanase, Yasuhito
    Kawaguchi, Ryuji
    Ohbayashi, Chiho
    Kobayashi, Hiroshi
    Hirai, Toshiko
    Kichikawa, Kimihiko
    JAPANESE JOURNAL OF RADIOLOGY, 2018, 36 (07) : 429 - 436
  • [34] Uterine endometrial carcinoma with DNA mismatch repair deficiency: magnetic resonance imaging findings and clinical features
    Kiyoyuki Minamiguchi
    Junko Takahama
    Tomoko Uchiyama
    Ryosuke Taiji
    Natsuhiko Saito
    Hiroshi Okada
    Nagaaki Marugami
    Yasuhito Tanase
    Ryuji Kawaguchi
    Chiho Ohbayashi
    Hiroshi Kobayashi
    Toshiko Hirai
    Kimihiko Kichikawa
    Japanese Journal of Radiology, 2018, 36 : 429 - 436
  • [35] Mismatch Repair Deficiency in Sporadic Colorectal Cancers
    任舒月
    陈春生
    任常山
    Chinese Medical Sciences Journal, 1998, (02) : 127 - 127
  • [36] SCREENING FOR MISMATCH REPAIR DEFICIENCY IN COLORECTAL CANCER
    Delahunty, R.
    McMurrick, P.
    Carne, P.
    Shapiro, J.
    Oliva, K.
    Wilkins, S.
    Baranyai, E.
    Antill, Y. C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 : 52 - 52
  • [37] Immunotherapy in Colorectal Cancer With Mismatch Repair Deficiency
    Overman, Michael J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (05) : 265 - 267
  • [38] An Optimized Pentaplex PCR for Detecting DNA Mismatch Repair-Deficient Colorectal Cancers
    Goel, Ajay
    Nagasaka, Takeshi
    Hamelin, Richard
    Boland, C. Richard
    PLOS ONE, 2010, 5 (02):
  • [39] Loss of SATB2 Expression in Colorectal Carcinoma Is Associated with DNA Mismatch Repair Protein Deficiency and Poor Survival
    Olevian, Dane
    Pai, Reetesh
    MODERN PATHOLOGY, 2018, 31 : 293 - 293
  • [40] Loss of SATB2 Expression in Colorectal Carcinoma Is Associated with DNA Mismatch Repair Protein Deficiency and Poor Survival
    Olevian, Dane
    Pai, Reetesh
    LABORATORY INVESTIGATION, 2018, 98 : 293 - 293